Shihezi University
5
0
0
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Evaluation and Treatment Strategy Development of Coronary Heart Disease Guided by OCT Based on Multimodal Deep Learning
Role: collaborator
Research on the Diagnostic Value of Machine Learning Model Based on Clinical Data in Patients With Coronary Heart Disease
Role: collaborator
A Multicenter Study on Early Diagnosis of NSTE-ACS Patients Based on Machine Learning Model
Role: collaborator
the New Biomarker of the Knee Osteoarthritis Knee Osteoarthritis Occurrence and Progression
Role: lead
Transitional Care Interventions for Patients With Cirrhosis Post-TIPS
Role: lead
All 5 trials loaded